{"id":"https://openalex.org/W2121123486","doi":"https://doi.org/10.1677/erc.1.01297","title":"Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer","display_name":"Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer","alternate_titles":[],"publication_year":2006,"publication_date":"2006-12-01","ids":{"openalex":"https://openalex.org/W2121123486","doi":"https://doi.org/10.1677/erc.1.01297","mag":"2121123486","pmid":"https://pubmed.ncbi.nlm.nih.gov/17259559"},"language":"en","primary_location":{"id":"doi:10.1677/erc.1.01297","doi":"https://doi.org/10.1677/erc.1.01297","is_oa":false,"landing_page_url":"https://doi.org/10.1677/erc.1.01297","pdf_url":null,"source":{"id":"https://openalex.org/S193349529","display_name":"Endocrine Related Cancer","issn_l":"1351-0088","issn":["1351-0088","1479-6821"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-Related Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2121123486"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007340763","display_name":"Stephen Hiscox","orcid":"https://orcid.org/0000-0002-3535-3100","observed_orcids":["https://orcid.org/0000-0002-3535-3100"]},"institutions":[{"id":"https://openalex.org/I4210152034","display_name":"Tenovus Cancer Care","ror":"https://ror.org/041t5x242","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210152034"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen Hiscox","raw_affiliation_strings":["Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, Wales CF10 3XF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, Wales CF10 3XF, UK","institution_ids":["https://openalex.org/I4210152034"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087563775","display_name":"Liam D. Morgan","orcid":"https://orcid.org/0000-0002-7571-6025","observed_orcids":["https://orcid.org/0000-0002-7571-6025"]},"institutions":[{"id":"https://openalex.org/I4210152034","display_name":"Tenovus Cancer Care","ror":"https://ror.org/041t5x242","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210152034"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L Morgan","raw_affiliation_strings":["Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, Wales CF10 3XF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, Wales CF10 3XF, UK","institution_ids":["https://openalex.org/I4210152034"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Tim Green","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tim Green","raw_affiliation_strings":["1AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113528089","display_name":"Robert I. Nicholson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152034","display_name":"Tenovus Cancer Care","ror":"https://ror.org/041t5x242","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210152034"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Robert I Nicholson","raw_affiliation_strings":["Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, Wales CF10 3XF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, Wales CF10 3XF, UK","institution_ids":["https://openalex.org/I4210152034"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6288,"has_fulltext":false,"cited_by_count":62,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.46621622,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"13","issue":"Supplement_1","first_page":"S53","last_page":"S59"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.7416999936103821,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.13609999418258667,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0729999989271164,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/src-kinase","display_name":"Src kinase","score":0.968999981880188},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.7319999933242798},{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9010000228881836},{"id":"https://openalex.org/keywords/azd0530","display_name":"AZD0530","score":0.8820000290870667},{"id":"https://openalex.org/keywords/cell-invasion","display_name":"cell invasion","score":0.5099999904632568},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.9819999933242798},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8550000190734863},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6919999718666077}],"concepts":[{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.719218373298645},{"id":"https://openalex.org/C2775960820","wikidata":"https://www.wikidata.org/wiki/Q408378","display_name":"Growth factor","level":3,"score":0.5623243451118469},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.561836838722229},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5538581013679504},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.5135445594787598},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.43828222155570984},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.4367583394050598},{"id":"https://openalex.org/C26375932","wikidata":"https://www.wikidata.org/wiki/Q118226","display_name":"Growth factor receptor","level":3,"score":0.43485569953918457},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.4345245659351349},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4188656806945801},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39347538352012634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3724425733089447},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36906033754348755},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36131787300109863},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3388800621032715},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3223155736923218}],"mesh":[{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004815","descriptor_name":"Epidermal Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009361","descriptor_name":"Neoplasm Invasiveness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015820","descriptor_name":"Cadherins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D016392","descriptor_name":"Proto-Oncogene Proteins pp60(c-src)","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016392","descriptor_name":"Proto-Oncogene Proteins pp60(c-src)","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D021982","descriptor_name":"Cell-Matrix Junctions","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D051177","descriptor_name":"Catenins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1677/erc.1.01297","doi":"https://doi.org/10.1677/erc.1.01297","is_oa":false,"landing_page_url":"https://doi.org/10.1677/erc.1.01297","pdf_url":null,"source":{"id":"https://openalex.org/S193349529","display_name":"Endocrine Related Cancer","issn_l":"1351-0088","issn":["1351-0088","1479-6821"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319937","host_organization_name":"Bioscientifica","host_organization_lineage":["https://openalex.org/P4310319937"],"host_organization_lineage_names":["Bioscientifica"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-Related Cancer","raw_type":"journal-article"},{"id":"pmid:17259559","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17259559","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrine-related cancer","raw_type":"Journal Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:66498","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/66498/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320320264","display_name":"Tenovus","ror":"https://ror.org/041t5x242"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":66,"referenced_works":["https://openalex.org/W27614701","https://openalex.org/W1481048846","https://openalex.org/W1497802607","https://openalex.org/W1532635242","https://openalex.org/W1627110251","https://openalex.org/W1785533687","https://openalex.org/W1792978156","https://openalex.org/W1845277443","https://openalex.org/W1854123316","https://openalex.org/W1889928106","https://openalex.org/W1965246509","https://openalex.org/W1967385749","https://openalex.org/W1977455794","https://openalex.org/W1979067350","https://openalex.org/W1981005324","https://openalex.org/W1991541715","https://openalex.org/W1999444744","https://openalex.org/W2005076200","https://openalex.org/W2005631145","https://openalex.org/W2009722391","https://openalex.org/W2012156861","https://openalex.org/W2024161072","https://openalex.org/W2024262880","https://openalex.org/W2025005089","https://openalex.org/W2025827059","https://openalex.org/W2026056764","https://openalex.org/W2035478190","https://openalex.org/W2035810660","https://openalex.org/W2037297522","https://openalex.org/W2043761739","https://openalex.org/W2045792003","https://openalex.org/W2047392037","https://openalex.org/W2049761405","https://openalex.org/W2053252897","https://openalex.org/W2053582875","https://openalex.org/W2059854067","https://openalex.org/W2062713892","https://openalex.org/W2071601082","https://openalex.org/W2073104464","https://openalex.org/W2078179718","https://openalex.org/W2081089603","https://openalex.org/W2081427703","https://openalex.org/W2093163249","https://openalex.org/W2101257013","https://openalex.org/W2105762021","https://openalex.org/W2106000067","https://openalex.org/W2107815302","https://openalex.org/W2114646523","https://openalex.org/W2124254102","https://openalex.org/W2124792927","https://openalex.org/W2128605357","https://openalex.org/W2132798818","https://openalex.org/W2132950000","https://openalex.org/W2139471842","https://openalex.org/W2142364395","https://openalex.org/W2143759076","https://openalex.org/W2148320836","https://openalex.org/W2148601288","https://openalex.org/W2148802069","https://openalex.org/W2151257470","https://openalex.org/W2154524184","https://openalex.org/W2156609440","https://openalex.org/W2182085413","https://openalex.org/W2318160598","https://openalex.org/W2332502334","https://openalex.org/W2336058699"],"related_works":["https://openalex.org/W2039469642","https://openalex.org/W1686223329","https://openalex.org/W2339871626","https://openalex.org/W2133910128","https://openalex.org/W2027046915","https://openalex.org/W2045792003","https://openalex.org/W2079956098","https://openalex.org/W1548879303","https://openalex.org/W2080332355","https://openalex.org/W27614701"],"abstract_inverted_index":{"Endocrine":[0],"therapy":[1],"is":[2,21,75],"the":[3,13,25,67,101,116,134,146,175,185,208,214],"treatment":[4],"of":[5,15,24,27,42,69,103,111,148,177,187,216],"choice":[6],"in":[7,38,72,100,132,151,203],"hormone":[8],"receptor-positive":[9],"breast":[10,73,205],"cancer.":[11],"However,":[12],"effectiveness":[14],"anti-hormone":[16,43,140],"drugs,":[17],"such":[18],"as":[19,200],"tamoxifen,":[20],"limited":[22],"because":[23],"development":[26,102],"resistance,":[28,44],"ultimately":[29,173],"leading":[30],"to":[31,55,158,210,219],"disease":[32],"progression":[33],"and":[34,82,107,141,170,172],"patient":[35],"mortality.":[36],"Using":[37,115],"vitro":[39],"cell":[40,167],"models":[41],"we":[45,123],"have":[46,64,124],"previously":[47],"demonstrated":[48],"that":[49,66,137,184],"altered":[50],"growth":[51,95],"factor":[52,90,143,155,221],"signalling":[53],"contributes":[54],"an":[56,93,201],"endocrine":[57,70],"insensitive":[58],"phenotype.":[59,84,114,180],"Significantly,":[60],"our":[61],"recent":[62],"studies":[63],"revealed":[65],"acquisition":[68,215],"resistance":[71,218],"cancer":[74],"accompanied":[76],"by":[77],"a":[78,104,108,126,162,178,192],"greatly":[79],"enhanced":[80],"migratory":[81],"invasive":[83,113,135],"Furthermore,":[85],"therapeutic":[86,194],"intervention":[87,195],"using":[88],"anti-growth":[89,142,154,220],"monotherapies,":[91],"despite":[92],"initial":[94],"suppressive":[96],"phase,":[97],"again":[98],"results":[99],"resistant":[105,179],"state":[106],"further":[109],"augmentation":[110],"their":[112],"dual":[117],"specific":[118],"Src/Abl":[119],"kinase":[120,131],"inhibitor,":[121],"AZD0530,":[122],"highlighted":[125],"central":[127],"role":[128],"for":[129],"Src":[130,149,188],"promoting":[133],"phenotype":[136],"accompanies":[138],"both":[139],"resistance.":[144],"Importantly,":[145],"use":[147],"inhibitors":[150],"combination":[152],"with":[153,207],"therapies":[156],"appears":[157],"be":[159],"additive,":[160],"producing":[161],"marked":[163],"inhibitory":[164],"effect":[165],"on":[166],"growth,":[168],"migration":[169],"invasion":[171],"prevents":[174],"emergence":[176],"These":[181],"observations":[182],"suggest":[183],"inhibition":[186],"activity":[189],"may":[190],"present":[191],"novel":[193],"strategy,":[196],"particularly":[197],"when":[198],"used":[199],"adjuvant":[202],"endocrine-resistant":[204],"disease,":[206],"potential":[209],"delay":[211],"or":[212],"prevent":[213],"subsequent":[217],"therapies.":[222]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2121123486","counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
